Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis

Peer Review reports

Original Submission
1 Mar 2022	Submitted	Original manuscript
8 Apr 2022	Reviewed	Reviewer Report
26 May 2022	Reviewed	Reviewer Report - Julianna Desmarais
14 Jun 2022	Author responded	Author comments - Huai Leng Pisaniello
Resubmission - Version 2
14 Jun 2022	Submitted	Manuscript version 2
21 Jun 2022	Reviewed	Reviewer Report
26 Jun 2022	Reviewed	Reviewer Report - Julianna Desmarais
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
7 Jul 2022	Editorially accepted
15 Nov 2022	Article published	10.1186/s41927-022-00299-3

Back to article page